These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1345332)

  • 1. Cholesterol reduction in single and multifactor randomized trials: relationship to CHD incidence and total mortality as found by meta analysis of twenty-two trials.
    Holme I
    Blood Press Suppl; 1992; 4():29-34. PubMed ID: 1345332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [All mortality by cause of death. The challenge of coronary prevention].
    Fernández-Cruz A
    Rev Esp Cardiol; 1998; 51 Suppl 6():23-9. PubMed ID: 10050141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-benefit analysis of a plant sterol containing low-fat margarine for cholesterol reduction.
    Gerber A; Evers T; Haverkamp H; Lauterbach KW
    Eur J Health Econ; 2006 Dec; 7(4):247-54. PubMed ID: 16821072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diet and coronary heart disease.
    Oliver MF
    Hum Nutr Clin Nutr; 1982; 36(6):413-27. PubMed ID: 6298152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifactorial trial in the prevention of coronary heart disease: 3. Incidence and mortality results.
    Eur Heart J; 1983 Mar; 4(3):141-7. PubMed ID: 6345161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol, coronary heart disease and stroke: a review of published evidence from observational studies and randomized controlled trials.
    Huxley R; Lewington S; Clarke R
    Semin Vasc Med; 2002 Aug; 2(3):315-23. PubMed ID: 16222621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials.
    Birjmohun RS; Hutten BA; Kastelein JJ; Stroes ES
    J Am Coll Cardiol; 2005 Jan; 45(2):185-97. PubMed ID: 15653014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercholesterolemia and coronary heart disease in the elderly: a meta-analysis.
    Anum EA; Adera T
    Ann Epidemiol; 2004 Oct; 14(9):705-21. PubMed ID: 15380802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total serum cholesterol levels and mortality risk as a function of age. A report based on the Framingham data.
    Kronmal RA; Cain KC; Ye Z; Omenn GS
    Arch Intern Med; 1993 May; 153(9):1065-73. PubMed ID: 8481074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence.
    Preiss D; Sattar N
    Clin Endocrinol (Oxf); 2009 Jun; 70(6):815-28. PubMed ID: 19067719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of statin therapy in adults with coronary heart disease.
    Wilt TJ; Bloomfield HE; MacDonald R; Nelson D; Rutks I; Ho M; Larsen G; McCall A; Pineros S; Sales A
    Arch Intern Med; 2004 Jul; 164(13):1427-36. PubMed ID: 15249352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of multivariate predictive power of major risk factors for coronary heart diseases in different countries: results from eight nations of the Seven Countries Study, 25-year follow-up.
    Menotti A; Keys A; Blackburn H; Kromhout D; Karvonen M; Nissinen A; Pekkanen J; Punsar S; Fidanza F; Giampaoli S; Seccareccia F; Buzina R; Mohacek I; Nedeljkovic S; Aravanis C; Dontas A; Toshima H; Lanti M
    J Cardiovasc Risk; 1996 Feb; 3(1):69-75. PubMed ID: 8783033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease.
    Marchioli R; Marfisi RM; Carinci F; Tognoni G
    Arch Intern Med; 1996 Jun; 156(11):1158-72. PubMed ID: 8639010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing the effect of antihypertensive treatment on coronary morbidity and mortality.
    Wilhelmsen L
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():41-6; discussion 47. PubMed ID: 2691694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
    Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
    Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence.
    Holme I
    Circulation; 1990 Dec; 82(6):1916-24. PubMed ID: 2242517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The benefits of reducing cholesterol levels: the need to distinguish primary from secondary prevention. 1. A meta-analysis of cholesterol-lowering trials.
    Silberberg JS; Henry DA
    Med J Aust; 1991 Nov; 155(10):665-6, 669-70. PubMed ID: 1834922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consumption of trans fats and estimated effects on coronary heart disease in Iran.
    Mozaffarian D; Abdollahi M; Campos H; Houshiarrad A; Willett WC
    Eur J Clin Nutr; 2007 Aug; 61(8):1004-10. PubMed ID: 17268422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related macular degeneration and risk of coronary heart disease: the Atherosclerosis Risk in Communities Study.
    Wong TY; Tikellis G; Sun C; Klein R; Couper DJ; Sharrett AR
    Ophthalmology; 2007 Jan; 114(1):86-91. PubMed ID: 17198851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does lowering serum cholesterol levels lower coronary heart disease risk?
    Rossouw JE; Rifkind BM
    Endocrinol Metab Clin North Am; 1990 Jun; 19(2):279-97. PubMed ID: 2192874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.